NXP Semiconductors N.V. (NXPI)

NXP Semiconductors N.V. reported adjusted EPS of $4.20 on October 27, 2026, beating the $4.12 analyst estimate by 1.94%, yet the stock slipped 0.71% in the next session. That pattern has repeated: five of the last six reports beat estimates, and in four of those five cases the share price fell in the first session afterward. The stock sits near the middle of its 52-week range, with a trailing P/E of 19.92 against a sector median of 35.1, which is the main reason the CleaRank rating is Buy.

NXP has beaten EPS estimates in five of its last six reports. The beats were small, ranging from 1.21% to 2.35%, and the reaction was not consistent. In four of the five beats the share price fell in the first session, including a 7.00% drop after the July 28, 2026 report. The April 28, 2026 report was the exception, with a 25.55% rise in the first session. The October 27, 2026 report, with EPS of $4.20 against $4.12 expected, followed the same pattern with a 0.71% decline. For an investor, the earnings record shows that the stock is judged on guidance and expectations as much as on the headline number.

The trailing P/E of 19.92 is 43.2% below the sector median of 35.1, and the price-to-sales ratio of 4.78 is 37.1% below the sector median of 7.6. Trailing GAAP EPS of $13.13 supports the earnings base behind that multiple. A 32.30% operating margin and a 23.40% net margin are strong for a semiconductor company, and return on equity of 28.67% is well above the sector median of 13.4%. Debt-to-equity of 0.88 is moderate. These figures are the core of the valuation case, and they explain why the valuation factor carries so much weight in the CleaRank score.

Analysts expect revenue to grow 16.7% this fiscal year, so the growth gap is not expected to close quickly. The stock's one-year return of 27.51% and six-month return of a 11.10% decline show how sensitive the share price has been to shifts in sentiment about the company's growth path.

Of 30 analysts with a current rating, 21 rate the stock Buy or Strong Buy, 8 rate it Hold and 1 rates it Sell. Three months ago, 22 of 30 rated it Buy, so the number of Buy ratings has slipped by one. The median 12-month target of $300.00 is 14.7% above the price, with a range from $175.00 to $400.00. Insiders sold $15.6M of stock over the last 18 months across recent filings, against one open-market purchase worth $51K. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less signal than open-market buying.

The base case is that NXPI keeps trading as a profitable, cash-generating chipmaker whose share price moves on expectations rather than on beats alone. Analysts expect EPS to grow 28.5% this fiscal year to $15.17 and 20.9% next year to $18.34, and the median 12-month target of $300.00 sits 14.7% above the price. For that view to hold, revenue growth needs to keep pace with those EPS forecasts; the analysts' revenue estimate of $14.3B implies 16.7% growth this year, which is below the 24.2% sector median. A sustained slowdown in revenue growth, or another quarter where a beat is followed by a lower share price, would weaken the case. A clear acceleration in revenue, with margins holding near the reported 32.30% operating margin, would strengthen it. The stock's beta of 1.86 means it can move sharply with the broader market, so analyst targets should be read as forecasts rather than outcomes.

Nearest support is the 20-day EMA at $249.43, which the price sits about 4.86% above. Below it, the 200-day SMA at $247.39 is the next floor, followed by the 50-day SMA at $237.49. The 52-week low of $183.00 is the deepest support level below the price. Resistance starts at the 52-week high of $339.95, the nearest level above the price.